Medicine and Dentistry
Hepatocellular Carcinoma
74%
Neoplasm
73%
Transitional Cell Carcinoma
52%
Colorectal Carcinoma
41%
Diseases
32%
Diffuse Large B-Cell Lymphoma
30%
Epidermal Growth Factor Receptor
28%
Bladder Cancer
28%
Recurrent Disease
28%
Hepatitis B Virus
26%
Bladder
25%
Carcinogenesis
22%
Membrane Protein
22%
Biological Marker
19%
Metastatic Carcinoma
19%
Helicobacter pylori
19%
Upper Urinary Tract
19%
Overall Survival
16%
Clinical Significance
15%
Hodgkin's Lymphoma
14%
Germinal Center
14%
Virus
14%
Cancer Staging
14%
Cancer
14%
Epstein Barr Virus
14%
Malignant Neoplasm
13%
Immunohistochemistry
13%
Antigen Specificity
13%
Polypeptide
13%
Single Nucleotide Polymorphism
13%
Stromal Tumor
13%
Cancer Cell
13%
Lymph Node
12%
Pathologist
12%
In Vitro
12%
Hepatocyte
12%
Next Generation Sequencing
11%
Phosphotransferase
11%
Squamous Cell Carcinoma
11%
Tumor Recurrence
11%
Tumor Progression
11%
Hepatectomy
10%
B Cell
10%
Prognostic Factor
10%
Immunoglobulin G4
10%
Heterozygosity
10%
Carcinoma
10%
Protein P53
10%
Infusion
9%
Human Herpesvirus 8
9%
Epidermal Growth Factor
9%
Progression Free Survival
9%
Lymphadenopathy
9%
Intestinal Metaplasia
9%
Ascites
9%
Non Small Cell Lung Cancer
9%
Hemophagocytic Syndrome
9%
Bladder Carcinogenesis
9%
Superficial Bladder Cancer
9%
Epidermal Growth Factor Receptor 2
9%
Gamma Urogastrone
9%
Cholangiocarcinoma
8%
Hydroa Vacciniforme
8%
Receptor Family
8%
Cutaneous Lymphoma
8%
Kikuchi Disease
8%
Synapsin I
8%
Wart Virus
8%
Chondrosarcoma
8%
Platelet Derived Growth Factor Alpha Receptor
8%
Follicular Dendritic Cell Sarcoma
8%
Pediatrics
8%
Ras Signaling
8%
Lid
8%
Systemic Lupus Erythematosus
8%
Intraarterial Drug Administration
8%
Prohibitin
8%
Brain Metastasis
8%
Lung Cancer
8%
Osteopontin
8%
Antigen Expression
8%
Abdominal Cancer
8%
Cell Proliferation
8%
Protein Tyrosine Kinase
8%
Multivariate Analysis
8%
Integrin
8%
Immunoglobulin Producing Cell
8%
NK T Cell Lymphoma
8%
Prevalence
7%
T Cell
7%
Cell Migration
7%
Liver Tumor
7%
Lymphoproliferative Disease
7%
Nasopharynx Carcinoma
7%
Gastrointestinal Stromal Tumor
7%
T-Cell Lymphoma
7%
Cell Growth
7%
Tumor Cell
7%
Differential Diagnosis
7%
Chronic Hepatitis B
7%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Neoplasm
89%
Hepatitis B Virus
48%
Epidermal Growth Factor Receptor
48%
Colorectal Carcinoma
46%
Malignant Neoplasm
46%
Bladder Cancer
37%
Carcinogenesis
35%
Recurrent Disease
31%
Diseases
26%
Transitional Cell Carcinoma
26%
Chemotherapy
21%
Chronic Hepatitis B
21%
Tumor Growth
20%
Helicobacter pylori
19%
Overall Survival
18%
Liver Injury
17%
Lung Cancer
17%
Membrane Antigen
13%
Liver Carcinogenesis
13%
Progression Free Survival
13%
Tumor Recurrence
13%
Infection
13%
Membrane Protein
13%
Hepatitis B
12%
Non Small Cell Lung Cancer
12%
Inflammation
12%
Protein Tyrosine Kinase
12%
Protein P53
11%
Genistein
11%
Biological Marker
11%
Bladder Tumor
11%
Transgenic Mouse
10%
Phosphatidylinositol 3 Kinase
10%
Cancer Staging
10%
Hepatitis B Antigen
9%
Epidermal Growth Factor
9%
Bilirubin
9%
Cisplatin
9%
Tumor Suppressor Protein
9%
Survival Rate
9%
Alkaline Phosphatase
8%
Polypeptide
8%
Diffuse Large B Cell Lymphoma
8%
Epstein-Barr Virus
8%
Spasmolytic Agent
8%
Antiviral Drug
8%
Esomeprazole
8%
Hodgkin Disease
8%
Fibronectin
8%
Interferon
8%
Circulating Tumor DNA
8%
Abdominal Cancer
8%
Gastrointestinal Stromal Tumor
8%
Lung Hemorrhage
8%
Systemic Lupus Erythematosus
8%
NK T Cell Lymphoma
8%
Mouth Cancer
8%
Obstructive Jaundice
8%
Reflux Esophagitis
8%
Antiviral Therapy
8%
CYP2C19
8%
Receptor
8%
Integrin
8%
Nasopharynx Carcinoma
7%
Clinical Trial
7%
Alanine Aminotransferase
7%
Phosphotransferase
7%
Interleukin 6
7%
Survival Time
7%
Liver Cirrhosis
7%
Tumor Necrosis Factor
6%
Drug Resistance
6%
Disease Exacerbation
6%
Chronic Hepatitis
6%
Carcinoma
6%
Mouse Model
6%
Virus DNA
6%
Interleukin 16
6%
Liver Fibrosis
6%
Bladder Carcinogenesis
6%
Cell Viability
6%
Entecavir
6%
Cytotoxicity
5%
Intestine Metaplasia
5%
Immunoglobulin
5%
Mouth Squamous Cell Carcinoma
5%
microRNA
5%
Cyclin Dependent Kinase 1
5%
Ulcer
5%
Helicobacter Infection
5%
Hepatitis C Virus
5%
Side Effect
5%
Colon Carcinoma
5%
Protein Tyrosine Kinase Inhibitor
5%
Tumor Invasion
5%
CD8 Antigen
5%
Cancer Growth Factor
5%
Hepatitis B Virus X Protein
5%
Peptide Nucleic Acid
5%
Keyphrases
Hepatocellular Carcinoma
20%
EMP1
13%
Infusion Chemotherapy
13%
Hepatitis B Virus
9%
Human Cancer
9%
Tumorigenesis
9%
C-Met
8%
Diffuse Large B-cell Lymphoma (DLBCL)
8%
Poor Prognosis
8%
Electromagnetic Thermotherapy
8%
Epidermal Growth Factor
8%
Integrin
8%
Penile Squamous Cell Carcinoma
8%
Hodgkin Lymphoma
8%
Cluster of Differentiation 44 (CD44)
8%
Microscope Stage
8%
Helicobacter Pylori (H. pylori)
8%
Chromosomal Microarray
8%
Pharmaceutical Composition
8%
MiR-137
8%
Liver
8%
Metastasis
7%
Pre-S2 mutant
6%
Urological Diseases
6%
Ground Glass Hepatocytes
6%
Infected Patients
5%
Colorectal Cancer Patients
5%
Liver Tissue
5%
Fine-needle
5%
Spasmolytic Polypeptide-expressing Metaplasia
5%
KRAS mutant
5%
Prohibitin
5%
CD44 Expression
5%
Hepatocyte Growth Factor Receptor
5%
Endoplasmic Reticulum Stress Response
5%
Polymorphism
5%
Apoptosis
5%
Transitional Cell Bladder Cancer
5%
Tumor
5%
PreS2
5%
Immunohistochemical Expression
5%
P53 Protein Expression
5%
Pre-S mutants
5%
Liver Resection
5%
Human Bladder Cancer
5%